Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Sheil

Showing results (211-220 of 248) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|June 9, 1988
Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporineB M Hall, D J Tiller, I Hardie, et al.
Transplantation Proceedings|February 1, 1987
Australian multicentre trial in cadaver renal transplantation comparison of short- and long-term cyclosporine A therapy with conventional therapyB M Hall, A G Sheil, D J Tiller, et al.
Clinical Transplantation|January 5, 2000
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?A K Chui, A R Rao, G W McCaughan, et al.
Transplantation Proceedings|December 20, 2000
Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: a revisitA K Chui, L W Shi, A R Rao, et al.
Transplantation Proceedings|December 20, 2000
Liver transplantation in patients with transjugular intrahepatic portosystemic shuntsA K Chui, A R Rao, L W Shi, et al.
The International Journal of Artificial Organs|April 29, 1998
Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) modelA G Sheil, J Sun, D C Mears, et al.
Kidney International|August 1, 1985
Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporineB M Hall, D J Tiller, G G Duggin, et al.
Transplantation Proceedings|December 1, 1972
A controlled trial antilymphocyte globulin therapy (ALG) in manA G Sheil, D Mears, G E Kelly, et al.
Clinical Transplantation|March 27, 2001
Inferior liver allograft survival from cadaveric donors >50 years of age?D J Verran, A Gurkan, P Dilworth, et al.
Transplantation Proceedings|December 20, 2000
Primary graft dysfunction after liver transplantationA K Chui, L W Shi, A R Rao, et al.
Pageof 25

Showing results (211-220 of 248) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|June 9, 1988
Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporineB M Hall, D J Tiller, I Hardie, et al.
Transplantation Proceedings|February 1, 1987
Australian multicentre trial in cadaver renal transplantation comparison of short- and long-term cyclosporine A therapy with conventional therapyB M Hall, A G Sheil, D J Tiller, et al.
Clinical Transplantation|January 5, 2000
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?A K Chui, A R Rao, G W McCaughan, et al.
Transplantation Proceedings|December 20, 2000
Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: a revisitA K Chui, L W Shi, A R Rao, et al.
Transplantation Proceedings|December 20, 2000
Liver transplantation in patients with transjugular intrahepatic portosystemic shuntsA K Chui, A R Rao, L W Shi, et al.
The International Journal of Artificial Organs|April 29, 1998
Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) modelA G Sheil, J Sun, D C Mears, et al.
Kidney International|August 1, 1985
Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporineB M Hall, D J Tiller, G G Duggin, et al.
Transplantation Proceedings|December 1, 1972
A controlled trial antilymphocyte globulin therapy (ALG) in manA G Sheil, D Mears, G E Kelly, et al.
Clinical Transplantation|March 27, 2001
Inferior liver allograft survival from cadaveric donors >50 years of age?D J Verran, A Gurkan, P Dilworth, et al.
Transplantation Proceedings|December 20, 2000
Primary graft dysfunction after liver transplantationA K Chui, L W Shi, A R Rao, et al.
Pageof 25